Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 9 | 5 | 2015 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2012 | 2016 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2016 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2012 | 2012 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.100 | None | 0 | 0 |